[1]何卫东,刘明春,陈秋月,等.育龄妇女风疹病毒化学发光法检测结果分析[J].医学信息,2018,31(16):145-147151.[doi:10.3969/j.issn.1006-1959.2018.16.046]
　HE Wei-dong,LIU Ming-chun,CHEN Qiu-yue,et al.Analysis of Detection Results of Rubella Virus by Chemiluminescence Method in Women of Childbearing Age[J].Journal of Medical Information,2018,31(16):145-147151.[doi:10.3969/j.issn.1006-1959.2018.16.046]
点击复制

育龄妇女风疹病毒化学发光法检测结果分析()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年16期
页码:
145-147151
栏目:
诊疗技术
出版日期:
2018-08-15

文章信息/Info

Title:
Analysis of Detection Results of Rubella Virus by Chemiluminescence Method in Women of Childbearing Age
文章编号:
1006-1959（2018）16-0145-04
作者:
何卫东; 刘明春; 陈秋月; 邱晓蔚; 杨宝圩; 蔡月真
福建省石狮市妇幼保健院检验科，福建 石狮 352700
Author(s):
HE Wei-dong; LIU Ming-chun; CHEN Qiu-yue; QIU Xiao-wei; YANG Bao-wei; CAI Yue-zhen
Department of Clinical Laboratory,Shishi Maternal and Child Health Care Hospital,Shishi 352700,Fujian,China
关键词:
化学发光免疫分析法; 风疹病毒; IgM; IgG; 育龄妇女
Keywords:
Key words：Chemiluminescent immunoassay; Rubella virus; IgM; IgG; Women of childbearing age
分类号:
R446.6
DOI:
10.3969/j.issn.1006-1959.2018.16.046
文献标志码:
B
摘要:
目的 使用化学发光免疫分析技术对孕前及孕早期育龄妇女进行风疹病毒定量检测，通过对检测结果进行分析，了解本地区孕前及孕早期妇女风疹病毒的感染状况，为制定孕前及孕早期保健措施提供依据。方法 对2015年5月~2018年4月来我院进行孕前检查和孕早期建卡的1052例育龄妇女进行风疹病毒特异性抗体IgM和IgG的定量检测，并对检测结果进行统计分析。结果 育龄妇女中RV-IgM总阳性率为0.86%，RV-IgG总阳性率为80.13%。曾经感染过风疹病毒或接种疫苗有保护性抗体（IgM-/IgG+）总体比例为79.46%（836/1052），对风疹病毒易感的妇女（IgM-/IgG-）总体比例为19.68%（207/1052）。孕前组及孕早期组（IgM-/IgG-）比例分别为9.20%、27.07%，总体比例为19.68%；（IgM-/IgG+）比例分别为89.43%、72.45%，总体比例为79.46%；（IgM+/IgG-）比例分别为0.46%、0，总体比例为0.19%；（IgM+/IgG+）比例分别为0.92%、0.49%，总体比例为0.67%。孕前组RV-IgM及RV-IgG阳性率高于孕早期组，差异有统计学意义（P＜0.05）。结论 CLIA法对风疹病毒IgM 抗体和IgG抗体的准确检测，为诊断和随访风疹病毒急性感染，评估孕前及孕早期育龄妇女的免疫状态，以及为可疑育龄妇女选择适当的预防措施提供了基本的工具和依据。RV-IgG 阳性率较高，对育龄妇女具有一定的保护作用，防治重点可放于RV-IgG阴性的育龄妇女。
Abstract:
Abstract：Objective To quantitatively detect rubella virus in women of pre-pregnancy and early pregnancy age by chemiluminescence immunoassay,and to analyze the results of the detection.So that to understand the status of rubella virus infection in pre-pregnancy and early pregnant women in this area,and to provide evidence for the establishment of pre-pregnancy and early pregnancy health care measures.Methods From May 2015 to April 2018,1052 women of childbearing age who underwent prenatal examination and early pregnancy card building were examined for rubella virus specific antibody IgM and IgG,and the results were analyzed statistically.Results The total positive rate of RV-IgM in women of childbearing age was 0.86%,and the total positive rate of RV-IgG was 80.13%.79.46% of them(836/1052)had previously been infected with rubella virus or vaccinated with protective antibodies(IgM-/IgG+).The overall proportion of women susceptible to rubella virus(IgM-/IgG-)was 19.68%(207/1052).The proportion of pre-pregnancy group and early pregnancy group(IgM-/IgG-)was 9.20% and 27.07% respectively,and the overall proportion was 19.68%.(IgM-/IgG+)ratio was 89.43%,72.45%,the overall ratio was 79.46%;(IgM+/IgG-)ratio was 0.46%,0,the overall ratio was 0.19%;The ratio of(IgM+/IgG+)was 0.92% and 0.49%,respectively,and the overall ratio was 0.67%.The positive rate of RV-IgM and RV-IgG in the pre-pregnancy group was higher than that in the early pregnancy group,the difference was statistically significant(P<0.05). Conclusion The accurate detection of rubella virus IgM antibody and IgG antibody by CLIA method can be used to diagnose and follow up the acute rubella virus infection and to evaluate the immune status of women of pre-pregnancy and early pregnancy age,it also provides basic tools and basis for selecting appropriate preventive measures for women of pregnancy age.The positive rate of RV-IgG was higher,and it had a certain protective effect on women of childbearing age.The emphasis of prevention and treatment could be placed on women of childbearing age with negative RV-IgG.

参考文献/References:

[1]汪延希,陈少珍.孕前优生规范化咨询模式建设的实证研究[J].国际检验医学杂志,2016,37(10):1423-1424.
[2]梁贵方,王成新.5180例女性婚前检查风疹病毒抗体的综合分析[J].中国当代医药,2013,20(14):174-175.
[3]李国正,高章圈,张芬心,等.孕前优生健康检查工作经验初探[J].中国计划生育学杂志,2012,20(7):497-498.
[4]全军计划生育优生优育专业委员会.妊娠期TORCH筛查指南[J].解放军医药杂志,2014,26(1):102-116. 5]梁宇,马琳娜.杭州地区育龄妇女和新生儿TORCH的检测结果分析[J].中国卫生检验杂志,2017(9):1274-1275.
[6]茹金城,单平囡,李三验.绍兴地区育龄妇女TORCH感染情况分析[J].中国妇幼保健,2016,31(6):1185-1186.
[7]Wang Y,Hedman L,Perdomo MF,et al.Microsphere-based antibody assays for human parvovirus B19V,CMV and T.gondii[J].BMC Infectious Diseases,2016,16(1):8.
[8]崔文彩,刘凤洁.370例孕前检查女性TORCH感染情况分析[J].国际病毒学杂志,2016,23(1):41-43.
[9]崔京涛,马良坤,倪安平,等.2008至2015年育龄妇女及新生儿TORCH血清学筛查及临床意义分析[J].中华检验医学杂志,2016,39(4):281-285.
[10]Yazigi A,De Pecoulas AE,Vauloup-Fellous C,et al.Fetal and neonatal abnormalities due to congenital rubella syndrome:a review of literature[J].J Matern Fetal Neonatal Med,2017,30(3):274-278.
[11]张立,许耀辉,陈道桢,等.无锡地区62141例育龄期妇女TORCH检测结果与季节性变化的相关性分析[J].安徽医药,2017,21(12):2229-2232.
[12]肖兵,万虹,谢成彬,等.6018例孕前及孕早期妇女风疹及巨细胞病毒感染状况的分析[J].实用妇产科杂志,2013,29(7):509-512.
[13]梁福笑,余勋,叶婉玲,等.东莞地区育龄妇女孕前、孕早期TORCH筛查研究[J].中国当代医药,2018(3):129-131.
[14]林立鹏,刘泽滨,王斌,等.首胎孕妇及二胎孕妇的TORCH临床感染情况[J].检验医学与临床,2017,14(8):1179-1181.
[15]吴敏芳,董明治.曲靖地区TORCH感染情况分析[J].国际检验医学杂志,2017,38(5):601-603.
[16]刘颖,申爽,奉淼.化学发光免疫分析技术在孕妇产前TORCH检测中的临床意义[J].中国民康医学,2015,27(1):23-24.

相似文献/References:

[1]谢春燕.化学发光免疫分析法在甲状腺疾病诊断中的应用[J].医学信息,2019,32(16):169.[doi:10.3969/j.issn.1006-1959.2019.16.058]
　XIE Chun-yan.Application of Chemiluminescence Immunoassay in the Diagnosis of Thyroid Diseases[J].Journal of Medical Information,2019,32(16):169.[doi:10.3969/j.issn.1006-1959.2019.16.058]
[2]罗纯生,展秀君.化学发光免疫分析法与酶联免疫吸附试验法检测乙肝病毒感染标志物比较[J].医学信息,2022,35(09):175.[doi:10.3969/j.issn.1006-1959.2022.09.045]
　LUO Chun-sheng,ZHAN Xiu-jun.Comparison of Chemiluminescence Immunoassay and Enzyme-linked Immunosorbent Assay for Detection of HBV Infection Markers[J].Journal of Medical Information,2022,35(16):175.[doi:10.3969/j.issn.1006-1959.2022.09.045]

更新日期/Last Update: 2018-08-15